BDBM416192 8-(3,9-dioxa-7- azabicyclo[3.3.1]non-7-yl)-6- {[(1R,4S)-4-ethoxy-3,3- difluorocyclohexyl]carbonyl}- 6,11-dihydro-5H-pyrido[2,3- b][1,5]benzodiazepine::US10442819, Example 337

SMILES CCO[C@H]1CC[C@H](CC1(F)F)C(=O)N1Cc2cccnc2Nc2ccc(cc12)N1CC2COCC(C1)O2

InChI Key InChIKey=ZVNGURFXQCVMHV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 416192   

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM416192(8-(3,9-dioxa-7- azabicyclo[3.3.1]non-7-yl)-6- {[(1...)
Affinity DataIC50: 14nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent